Gladius Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Gladius Capital Management's LLY Position: Q2 2026 in Review
Gladius Capital Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 3,400 shares — an estimated $3.47M sold.
Gladius Capital Management first reported a position in LLY in Q4 2021 and held it in 16 quarters. The position peaked at $6.09M in Q4 2024. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Gladius Capital Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
- Gladius Capital Management sold 3,400 Eli Lilly shares in Q2 2026, an estimated $3.47M.
- Gladius Capital Management first reported a position in Eli Lilly in Q4 2021 and held it in 16 quarters.
- Gladius Capital Management's Eli Lilly position peaked at $6.09M in Q4 2024.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Gladius Capital Management's 13F filing for Q2 2026, filed 30 Jul 2026.